Association of Coffee Consumption With Peri-Implant Status

Completed

Conditions studied: Peri-Implant Health, Peri-Implantitis and Peri-implant Mucositis

In brief

A total of 123 participants (291 implants) applying to Bolu Abant İzzet Baysal University will be included in the study. Based on anamnesis, radiographic examination, and the 2018 classification of periodontal diseases, the participants will be categorized into three groups: peri-implant health (n = 97 implants), peri-implant mucositis (n = 97 implants), and peri-implantitis (n = 97 implants). Information regarding participants' coffee consumption habits and their daily coffee intake will be collected. Clinical parameters to be measured will include plaque index, gingival index, bleeding on probing, gingival recession, and clinical attachment level. The frequency of coffee consumption will be evaluated as daily, 1-2 times per week, 3-4 times per week, once per month, twice per month, and once per year. The amount of coffee consumed at a single occasion (cup, glass, mug, etc.) will also be recorded. In caffeinated coffee consumption, the preference for weak, moderate, or strong coffee, as well as consumption with milk, condensed milk, sugar, honey, or sweeteners will be assessed. For Turkish coffee, the consumption pattern will be categorized as unsweetened, moderately sweetened, or sweetened.

Key facts

Study ID

NCT07747558

Run by

Tuğba ŞAHİN

People needed

291

Starts

2024-12-07

Expected to finish

2026-05-30

Last updated by the study team

2026-08-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Being between 18 and 45 years of age.
• Having one or more fixed prosthesis-supported dental implants, with at least one year and no more than five years having passed since the functional prosthetic loading of the dental implant(s).

You may not qualify if…

• Having smoked more than 100 cigarettes during their lifetime.
• Being an active smoker.
• Having uncontrolled diabetes mellitus.
• Use of antibiotics or anti-inflammatory medications.
• Pregnant or breastfeeding women.
• Patients who received treatment for peri-implant disease after implant placement.
• Presence of residual cement remnants.
• Having malpositioned implants.
• Receiving active periodontal treatment.

Where it is running

• Bolu Abant İzzet Baysal University — Bolu, Bolu, Turkey (Türkiye)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.